What is one potential consequence of abruptly discontinuing MAT?

Abruptly discontinuing Medication-Assisted Treatment (MAT) can lead to a heightened risk of relapse and severe withdrawal symptoms for individuals in recovery from substance use disorders. When a person stops taking medications such as buprenorphine or methadone suddenly, their body—which has adapted to the presence of these medications—may react negatively. This can result in intense cravings for the substance they were being treated for, as well as physical and psychological withdrawal symptoms that can be quite severe, including nausea, anxiety, and insomnia.

The risk of relapse is particularly pronounced because the individual may return to drug use in an attempt to alleviate these withdrawal symptoms. Therefore, maintaining consistency in treatment is crucial for sustaining recovery and minimizing these risks. This understanding is foundational in MAT practices, as structured and gradual tapering is often recommended instead of abrupt discontinuation, to support the individual's recovery journey effectively.